| |
|
|
|
Harvard Bioscience Inc.  
|
|
2.08 0.02 (0.01%) |
06-21 16:00 |
|
Open: |
2.04 |
Pre close: |
2.06 |
Target:
|
2.66
|
|
High: |
2.13 |
Low: |
2.02 |
Resistance:
|
2.28
2.50
|
|
Volume: |
270,970 |
Market Cap: |
78M |
Support:
|
1.92
1.60
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.06
|
MACD |
MACD(12,26):
|
-0.19  |
|
MA(20): |
2.11  |
Signal(12,26,9): |
-0.24 |
|
MA(100): |
3.35 |
Stochastic Oscillator |
%K(14,3):
|
30.40 |
|
MA(250): |
4.10 |
%D(3): |
29.27 |
|
Average Volume(K) |
3-Month: |
26745
|
52-Week |
High:
|
6.70 |
|
10-Days: |
52795 |
Low: |
1.92 |
|
RSI |
RSI(14):
|
35.67 |
Change(%): |
-60.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.037 |
Return on Equity (ttm) |
-1.0 |
Shares Out. (M) |
37.69 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
1.7 |
Shares Float (M) |
33.77 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
1.22 |
% Held by Insiders |
12.87 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
5.4 |
% Held by Institutions |
74.11 |
|
Forward EPS |
0.260 |
Gross Profit (p.s.) |
1.777 |
Shares Short (K) |
828 |
|
Book Value (p.s.) |
2.130 |
EBITDA (p.s.) |
0.336 |
P/E |
-56.22 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.98 |
|
Profit Margin |
-1.00 |
Operating Cash Flow
(M) |
4.45 |
P/S |
23756120.00 |
|
Operating Margin |
3.75 |
Levered Free Cash Flow
(M) |
9.81 |
P/CF |
17.62 |
|
|
|
|
|
|
